c o m m e n ta ry
Gastric bypass surgery as a treatment for obesity is increasing in prevalence, partly because of the development of safe surgical techniques associ ated with a reduced incidence of postoperative complications. The popularity of such procedures is also fuelled by the knowledge that substantial weight loss reduces comorbidities. However, severe obesity is associated with subtle abnor malities in boneregulating hormones, includ ing low serum levels of vitamin D and secondary hyperparathyroidism. Furthermore, patients may be at risk of low BMD after gastric bypass surgery because of reduced calcium absorption and inadequate intakes of calcium, vitamin D or other nutrients. Although gastric bypass surgery reduces comorbidities, the longterm consequences of extreme weight loss on bone are unclear.
Fleisher et al. 2 examined bone loss in 23 patients (mean BMI 47 kg/m 2 ) before and 1 year after RouxenY gastric bypass. At 12 months, mean participants' weight loss was 45 kg and their levels of bone turnover markers had increased. BMD had decreased at the femoral neck (9.2%) and total hip (8.0%), but was unchanged at the lumbar spine and distal radius. Calcium regulating hormones generally remained at base line levels despite a marked increase in dietary calcium and vitamin D after surgery, although transient changes in these hormones occurred 3 months after surgery.
Summary
This Practice Point commentary discusses a prospective study by Fleisher et al. that showed bone loss in response to extreme weight loss in 23 patients following Roux-en-Y gastric bypass surgery. The decline in BMD at the hip, but not at the spine or distal radius, was found to be proportional to the extent of weight loss. Although dietary calcium and vitamin D intake markedly increased after surgery, serum 25 hydroxyvitamin D, serum parathyroid hormone and urinary calcium levels remained at presurgery levels. Here, I highlight concerns about bone loss associated with severe weight loss, discuss mechanisms that might alter bone regulation during caloric restriction, and consider how diet might be used to prevent osteoporosis after weight-loss surgery.
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The findings of Fleisher et al. 2 support those of a prospective study by Coates et al. 3 that showed a 7.8% BMD loss at the total hip associated with a 37 kg weight reduction 9 months after gastric bypass surgery. Fleisher and colleagues' find ings are also consistent with those of a study that examined patients 3 years after gastric bypass surgery and found that hip BMD, but not lumbar spine BMD, decreased to values below those of weightmatched controls. 4 By contrast, Coates et al. 3 found a small decline in lumbar spine BMD after surgery.
In any case, BMD measurements by dual energy Xray absorptiometry are problematic in severely obese individuals because of the excess adipose tissue that overlies the bone and an increased prevalence of osteoarthritis. The preci sion of measured BMD changes during weight loss can also be compromised by changes in body size. 5 To address possible inaccuracies, Fleisher et al. also calculated the apparent BMD (a volu metric estimation of bone density) at the femoral neck; that showed a smaller, but still significant, BMD loss. 2 Bone loss could alternatively be determined at a peripheral site where one would expect a smaller change in excess weight, such as the distal radius; interestingly, neither Fleisher et al. nor Coates et al. found bone loss at this site. However, the radius is often associated with high measurement variability. Bone loss at the hip, but not the spine, has also been observed with moderate weight loss. 
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be related to the effects of elevated parathyroid hormone (PTH) levels, which cause more loss at cortical than trabecular bone sites; 6 alterna tively, weightbearing sites, for example the hip, might be more vulnerable to the effects of weight reduction than other sites, such as the lumbar spine and radius.
Compared with participants in the study by Fleisher et al, 2 the 42 women in the study by Carrasco et al. 7 lost less weight (39 kg) but experienced greater declines in BMD (10.5% and 7.4% at the hip and spine, respectively). Many factors could explain these increased BMD losses, including the use of different instruments, the participants' lower initial body weight, or the use of an exclusively female population. Furthermore, participants in the study by Carrasco et al. had a lower daily dietary intake of vitamin D (400-800 IU) and calcium (680-1,000 mg); 7 in the study by Fleisher et al., 2 daily dietary intake of calcium was 1,300 mg at baseline and 2,500 mg after surgery, whereas daily vitamin D intake was 700 IU at baseline and 1,700 IU after surgery. Possibly, the high intake of these nutrients before and after surgery had a positive effect on PTH levels and bone. Fleisher et al. 2 participants had normal levels of serum PTH presurgery and postsurgery, whereas PTH has been shown to be high both presurgery and postsurgery when calcium and vitamin D intakes were lower at about 1 g and 440 IU, respectively. 1 However, several studies 1-3 showed that participants had serum 25 hydroxyvitamin D levels in the insuf ficient range (below 75 nmol/l) both before and after surgery, which would compromise calcium absorption and have important implications for other diseases.
In the study by Fleisher et al., 2 the high intakes of dietary calcium and vitamin D after gastric bypass surgery were unable to suppress the transient rise in serum PTH levels, raise levels of 25 hydroxyvitamin D 2 or prevent bone loss. The findings were similar in studies in which participants' daily dietary intakes of these nutri ents were comparatively low (935-1700 mg calcium and 440-660 IU vitamin D). 1, 3, 7 Severely obese patients typically have increased BMD and calcium absorption levels; consequently, clinicians should not hesitate to recommend weight loss in this population because of bonehealth con cerns. Conversely, preliminary evidence suggests that cortical BMD might be compromised in severely obese people; therefore, an improved understanding of the longterm consequences of weight loss on bone is crucial. A daily dietary intake of 1200-1500 mg calcium and enough vitamin D to raise serum 25 hydroxyvitamin D levels to ≥75/nmol/L should be recommended. At the present time, it is not clear whether very high intakes of vitamin D are associated with increased benefits on bone.
Dietary intake is markedly reduced in patients after surgery, so vitamin and mineral supple ments must be recommended. Other modifiable risk factors, such as levels of activity, medications and other nutrients, might also have a role in bone health and should be considered in future studies that examine metabolic bone disease after gastric bypass surgery. 
PrACTICe PoINT
Patients who have undergone gastric bypass surgery should receive daily supplementation with 1200-1500 mg calcium and enough vitamin D to raise serum 25 hydroxyvitamin D levels to ≥75 nmol/l, normalize serum parathyroid hormone levels, and attenuate bone loss.
